Emergent Biosolutions

Yahoo Finance • last month

Top European Dividend Stocks For December 2025

As European markets continue to show resilience, with the STOXX Europe 600 Index climbing 2.35% and major single-country indexes also posting gains, investors are increasingly focusing on dividend stocks as a means to generate steady incom... Full story

Yahoo Finance • 2 months ago

Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge

Earnings Call Insights: Emergent BioSolutions Inc. (EBS) Q3 2025 MANAGEMENT VIEW * CEO Joseph Papa stated that "we had another great quarter and are on track to exceed our initial 2025 revenue and adjusted EBITDA guidance." He highligh... Full story

Yahoo Finance • 2 months ago

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 millionThird Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22%Third Quarter 2025 Gross Margin % of 54% and Adjusted Gross M... Full story

Yahoo Finance • 3 months ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

GAITHERSBURG, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, October 29, 2025, at 5:00 pm eastern time to discuss the financial results for the third quarter of 202... Full story

Yahoo Finance • 4 months ago

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to i... Full story

Yahoo Finance • 4 months ago

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 m... Full story

Yahoo Finance • 4 months ago

Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA

* Emergent BioSolutions (NYSE:EBS [https://seekingalpha.com/symbol/EBS]) announced on Monday it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority, part of the Administration... Full story

Yahoo Finance • 4 months ago

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), par... Full story

Yahoo Finance • 4 months ago

Mpox in Africa is no longer a global health emergency, WHO chief says

[Blood collection tubes Mpox test positive results,WHO to rename monkeypox as ‘Mpox’] JUN LI The mpox outbreak that originated from Africa last year can no longer be considered a global emergency due to a sustained decline in cases and im... Full story

Yahoo Finance • 4 months ago

Emergent Biosolutions awarded $30 million contract modification for CYFENDUS

* Emergent BioSolutions (NYSE:EBS [https://seekingalpha.com/symbol/EBS]) has received a $30 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic P... Full story

Yahoo Finance • 4 months ago

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), par... Full story

Yahoo Finance • 5 months ago

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Pro Football Hall of Famer and Ready to Rescue campaign spokesperson, Emmitt Smith, and Release Recovery Founder/CEO, Zac Clark, plan to visit several U.S. college campuses to educate on opioid emergency preparednessNew sponsorship of Mobi... Full story

Yahoo Finance • 5 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: Wells Fargo 20th An... Full story

Yahoo Finance • 5 months ago

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for Awareness and Facing F... Full story

Yahoo Finance • 5 months ago

Thursday's session: top gainers and losers

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. [topmovers] GAINERS TICKER CHANGE COMMENT IMG [https://www.chartmill.com/stock/quote/IMG/profile] 109.0% P... Full story

Yahoo Finance • 5 months ago

Traders are paying attention to the gapping stocks in Thursday's session.

Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT AVAH [https://www.chartmill.com/stock/quote/A... Full story

Yahoo Finance • 5 months ago

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Second Quarter 2025 Total Revenues of $140.9 million, above Q2 guidance by $21 millionSecond Quarter 2025 Net Loss of $12.0 million and Net Loss Margin of (9)%, an improvement of 96% and 10,200 bps, respectively, versus prior yearSecond Qu... Full story

Yahoo Finance • 5 months ago

Erste Group Q2 2025 slides reveal strong profit growth, improved outlook

Introduction & Market Context Erste Group Bank presented its Q2 2025 financial results on August 1, 2025, showcasing strong performance across key metrics. The Vienna-based banking group, which maintains a commanding presence across Centr... Full story

Yahoo Finance • 6 months ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the publication of a comprehensive review article, "Brincidofovir in the Era of Mpox," in the peer-reviewed journal Expert Review... Full story

Yahoo Finance • 6 months ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED location in its buil... Full story